Device supplier deemphasis on direct marketing recommended by Columbia/HCA exec.
This article was originally published in The Gray Sheet
Executive Summary
DEVICE SUPPLIER DIRECT SALES RESOURCE SHIFT TO CLINICAL CONSULTING should be implemented to meet the needs of consolidated health care providers, Michael Louviere, vice president of materials management at Columbia/ HCA, said Oct. 24 at a HIMA "customer conference" in Nashville, Tennessee. "I really do not think that the average company will need a large sales force in the future...What we really are looking for is sales initiative on our corporate level. Once that's sold, you really don't need salesmen to drive the sales in the field. We'll do that for you."
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.